Pulsetto is a healthtech company focused on practical applications of neuromodulation. Its device stimulates the vagus nerve – a key regulator of the parasympathetic nervous system – to help minimize stress responses and improve recovery.
Pulsetto grew its revenue from approximately $9 million in 2024 to more than $40 million in 2025, representing more than 4x year-over-year growth, while surpassing 300,000 users worldwide. During that same period, Pulsetto tripled its team size with expansion across engineering and medical research.
Central to Pulsetto's growth strategy is continued investment in clinical research and scientific credibility. The company has completed multiple studies examining the effects of non-invasive vagus nerve stimulation, with findings showing:
56% reduction in perceived stress
45% reduction in anxiety
41% improvement in sleep quality over a four-week period
Additional studies have demonstrated meaningful improvements in heart rate variability, migraine frequency, and pain management, spanning both everyday wellness and more complex health conditions.